<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02107989</url>
  </required_header>
  <id_info>
    <org_study_id>140061</org_study_id>
    <secondary_id>14-N-0061</secondary_id>
    <nct_id>NCT02107989</nct_id>
  </id_info>
  <brief_title>Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database</brief_title>
  <official_title>Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Institute of Neurological Disorders and Stroke (NINDS)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Institutes of Health Clinical Center (CC)</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Objectives:

      The overall study objective is to compare the sensitivities and specificities of morphometric
      analysis techniques using structural MRI images based on pre- and postsurgical localization
      of epileptic foci in patients undergoing presurgical evaluation for medically refractory
      epilepsy. To carry out these analyses, we aim to establish an age-stratified normative
      imaging database using healthy volunteers. Additional objectives are to identify abnormal
      networks in these patients using resting state fMRI/EEG and MEG/EEG, and to use language and
      memory fMRI tasks to examine the effects of epileptogenic zones and surgery on cognitive
      function and the networks associated with these functions.

      Study population:

      300 adults and children (age 8-65) with uncontrolled focal epilepsy, and 200 age-stratified
      healthy volunteers.

      Design: A retrospective and prospective natural history study. Research procedures for
      patients in this study include neuropsychological testing and 1-4 MRI sessions during
      presurgical evaluation and an additional 1-3 MRI sessions and neuropsychological testing
      approximately 12 months post-operatively. Research testing (such as research
      neuropsychological tests or MRI scanning sequences) will be done during a visit for clinical
      testing whenever possible, likely reducing the number of required visits. Patients will also
      have optional MEG and 7T structural imaging. Data will also be obtained from patients who
      have already undergone epilepsy surgery if they had procedures as outlined in the protocol
      and are willing to share the data. Healthy volunteers will receive a subset of the
      pre-operative procedures for patients, requiring at least 3 visits. In order to ensure
      adequate data acquisition, subjects may be re-scanned up to three times for the portions of
      the study in which they participated, possibly requiring additional visits.

      Outcome measures:

      The main outcomes will be establishment of normative values for morphometric analysis methods
      in age-stratified normal controls, and comparison of the sensitivity and specificity of these
      measures to pre- and postsurgical localization of the epileptogenic zone. Secondary outcome
      measures will include determination of the sensitivity and specificity of source localization
      using MEG/EEG and resting state fMRI/EEG, and to evaluate changes in activation during rest,
      as well as language and memory fMRI tasks in patients pre- and postsurgically, to examine the
      effects of epileptogenic zones and surgery on cognitive function and the networks underlying
      these functions.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objectives: The overall study objective is to compare the sensitivities and specificities of
      morphometric analysis techniques using structural MRI images based on pre- and postsurgical
      localization of epileptic foci in patients undergoing presurgical evaluation for medically
      refractory epilepsy. To carry out these analyses, we aim to establish an age-stratified
      normative imaging database using healthy volunteers. Additional objectives are to identify
      abnormal networks in these patients using resting state fMRI/EEG and MEG/EEG, and to use
      language and memory fMRI tasks to examine the effects of epileptogenic zones and surgery on
      cognitive function and the networks associated with these functions.

      Study population: 300 adults and children (age 8-65) with uncontrolled focal epilepsy, and
      200 age-stratified healthy volunteers.

      Design: A retrospective and prospective natural history study. Research procedures for
      patients in this study include neuropsychological testing and 1-4 MRI sessions during
      presurgical evaluation and an additional 1-3 MRI sessions and neuropsychological testing
      approximately 12 months post-operatively. Research testing (such as research
      neuropsychological tests or MRI scanning sequences) will be done during a visit for clinical
      testing whenever possible, likely reducing the number of required visits. Patients will also
      have optional MEG and 7T structural imaging. Data will also be obtained from patients who
      have already undergone epilepsy surgery if they had procedures as outlined in the protocol
      and are willing to share the data. Healthy volunteers will receive a subset of the
      pre-operative procedures for patients, requiring at least 3 visits. In order to ensure
      adequate data acquisition, subjects may be re-scanned up to three times for the portions of
      the study in which they participated, possibly requiring additional visits.

      Outcome measures:

      The main outcomes will be establishment of normative values for morphometric analysis methods
      in age-stratified normal controls, and comparison of the sensitivity and specificity of these
      measures to pre- and postsurgical localization of the epileptogenic zone.Exploratory outcome
      measures will include determination of the sensitivity and specificity of source localization
      using MEG/EEG and resting state fMRI/EEG, and to evaluate changes in activation during rest,
      as well as language and memory fMRI tasks in patients pre- and post-surgically, to examine
      the effects of epileptogenic zones and surgery on cognitive function and the networks
      underlying these functions.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 11, 2014</start_date>
  <completion_date type="Anticipated">March 30, 2026</completion_date>
  <primary_completion_date type="Anticipated">March 30, 2026</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Determine age-adjusted norms for morphometric analysis methods in healthy volunteers</measure>
    <time_frame>1 yr/ postoperatively</time_frame>
    <description>This will include surface and volume-based measures derived from high resolution T1, T2, FLAIR, and diffusion MR images.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To determine the sensitivity and specificity of these methods or combinations of these methods for detecting structural abnormalities underlying epileptogenic zones in individual patients</measure>
    <time_frame>1 yr/ postoperatively</time_frame>
    <description>a.Initial analysis of sensitivity and specificity will be based on comparison with pre-operative seizure focus determination based on conventional radiological MRI interpretation and scalp video-EEG monitoring. b.Final analysis will compare the sensitivity and specificity of these measures as well as conventional radiological MRI interpretation with seizure focus localization based on intracranial EEG findings and/or resection localization resulting in one year of seizure freedom</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Using data derived from normative database, localization of epileptic zone</measure>
    <time_frame>1 yr/ postoperatively</time_frame>
    <description>Determine normative values for resting-state fMRI/EEG analysis techniques (such as average connectedness, interhemispheric connectedness, connectivity patterns as described below) in the age-stratified control groups, and determine the sensitivity and specificity of each technique or combination of techniques for epileptogenic zone localization (as described in the primary outcome)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Using data derived from normative database, localize using morphometric analysis</measure>
    <time_frame>1 yr/ postoperatively</time_frame>
    <description>Determine normative values for resting-state EEG/MEG analysis techniques in the age-stratified control groups, and determine the sensitivity and specificity of these techniques for epileptogenic zone localization (as described in the primary outcome)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Using data derived from normative database, localization by conventional radiological visual interpretation</measure>
    <time_frame>1 yr/ postoperatively</time_frame>
    <description>Assess the ability of a fMRI memory paradigm (verbal and visual abstract memory paradigms) to lateralize memory function, and evaluate whether the laterality index is altered in epilepsy patients compared to controls, particularly in patients with impaired material-specific memory on neuropsychological testing</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Using data derived from normative database, determine sensitivity and specificity for each morphometric measure</measure>
    <time_frame>1 yr/ postoperatively</time_frame>
    <description>Evaluate whether resting-state fMRI networks, language or memory laterality indices, or neuropsychological measures are altered following epilepsy surgery, and whether neuroimaging changes are correlated with seizure outcome and/or changes in neuropsychological testing.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Epilepsy</condition>
  <arm_group>
    <arm_group_label>healthy volunteers</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>healthy volunteers will get diagnostic testing at time zero and year later</description>
  </arm_group>
  <arm_group>
    <arm_group_label>patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients will get diagnostic testing pre and post-operatively</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MRI</intervention_name>
    <description>MRI of the brain is routinely used to identify abnormal areas of cortex in patients with medically refractory epilepsy. MRI evaluations of brain may be performed at field strengths of 1.5 T, 3T, and/or 7T, under conditions designated by the FDA as constituting nonsignificant risk.</description>
    <arm_group_label>healthy volunteers</arm_group_label>
    <arm_group_label>patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MEG</intervention_name>
    <description>MEG/EEG:
Magnetoencephalogra phy (MEG) is commonly used during epilepsy pre- surgical evaluations to help with localizing epileptic foci. MEG will be obtained as clinically indicated, usually in patients with unclear seizure focus localization who are undergoing presurgical evaluation, particularly when they have frequent interictal discharges on EEG. MEG records very small magnetic fields generated by the brain at rest, or in response to a task or to epileptic activity. Resting state MEG/EEG analysis will be used for research purposes only.</description>
    <arm_group_label>patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        -  INCLUSION CRITERIA FOR PATIENTS:

          -  Age 8-65 years old

          -  Evaluated or under evaluation for epilepsy surgery under protocol 18-N-0066,11-N-0051
             or 16-N-0041

          -  Documentation of focal epilepsy based on MRI, EEG and/or ictal semiology

          -  Ability to give informed consent or have a legally authorized representative able to
             give consent (for adults without consent capacity) or parent/guardian able to provide
             informed consent (for a child).

        INCLUSION CRITERIA FOR PATIENTS SOLELY CONTRIBUTING DATA:

          -  Had epilepsy surgery with presurgical evaluation under 18-N-0066

          -  Age 8-65 at the time of epilepsy surgery evaluation

          -  Had a preoperative structural brain MRI of the type used in this protocol

        INCLUSION CRITERIA FOR HEALTHY VOLUNTEERS:

          -  Age 8-65 years old

          -  Ability to give informed consent or have a parent/guardian able to provide informed
             consent if a child.

          -  Ability to cooperate with MRI scanning without anesthesia

        EXCLUSION CRITERIA FOR PATIENTS:

          -  Contraindications to MRI or MEG studies (such as pacemakers, cochlear implants,
             shrapnel, permanent eyeliner)

          -  Claustrophobia or anxiety disorders exacerbated by the MRI scanner

          -  Pregnancy. All females of childbearing potential must have a negative pregnancy test
             prior to MRI scanning

        EXCLUSION CRITERIA FOR PATIENTS SOLELY CONTRIBUTING DATA:

        -Not able or willing to give consent or do not have an appropriate surrogate who can
        provide consent

        EXCLUSION CRITERIA FOR HEALTHY VOLUNTEERS:

          -  Contraindications to MRI or MEG studies (such as pacemakers, cochlear implants,
             shrapnel, permanent eyeliner)

          -  Claustrophobia or anxiety disorders exacerbated by the MRI scanner

          -  Significant medical conditions that may affect the central nervous system, such as
             psychiatric disorders (such as mood disorders, psychotic disorders, substance abuse or
             dependence), significant neurologic disorders (such as brain injury, neurodegenerative
             disorders, multiple sclerosis, stroke, movement disorders, epilepsy), or active
             systemic disease that may affect the central nervous system (such as uncontrolled
             hypertension, autoimmune disorders or other inflammatory disorders, neoplastic
             disease)

          -  Use of centrally acting medications in the past 6 weeks, such as benzodiazepines,
             barbiturates, antidepressants, beta-blockers, and drugs for treating epilepsy or
             migraine

          -  Pregnancy. All females of childbearing potential must have a negative pregnancy test
             prior to MRI scanning
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>8 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sara K Inati, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Institute of Neurological Disorders and Stroke (NINDS)</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Aaliyah H Hamidullah-Thiam</last_name>
    <phone>(301) 496-5121</phone>
    <email>aaliyah.hamidullahthiam@nih.gov</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sara K Inati, M.D.</last_name>
    <phone>(301) 435-6269</phone>
    <email>inatisk@mail.nih.gov</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>National Institutes of Health Clinical Center, 9000 Rockville Pike</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20892</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)</last_name>
      <phone>800-411-1222</phone>
      <phone_ext>TTY8664111010</phone_ext>
      <email>prpl@cc.nih.gov</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://clinicalstudies.info.nih.gov/cgi/detail.cgi?A_2014-N-0061.html</url>
    <description>NIH Clinical Center Detailed Web Page</description>
  </link>
  <reference>
    <citation>Aghakhani Y, Bagshaw AP, BÃ©nar CG, Hawco C, Andermann F, Dubeau F, Gotman J. fMRI activation during spike and wave discharges in idiopathic generalized epilepsy. Brain. 2004 May;127(Pt 5):1127-44. Epub 2004 Mar 19.</citation>
    <PMID>15033899</PMID>
  </reference>
  <reference>
    <citation>Anderson JS, Ferguson MA, Lopez-Larson M, Yurgelun-Todd D. Reproducibility of single-subject functional connectivity measurements. AJNR Am J Neuroradiol. 2011 Mar;32(3):548-55. doi: 10.3174/ajnr.A2330. Epub 2011 Jan 27.</citation>
    <PMID>21273356</PMID>
  </reference>
  <reference>
    <citation>Ansari SF, Tubbs RS, Terry CL, Cohen-Gadol AA. Surgery for extratemporal nonlesional epilepsy in adults: an outcome meta-analysis. Acta Neurochir (Wien). 2010 Aug;152(8):1299-305. doi: 10.1007/s00701-010-0697-3. Epub 2010 Jun 4. Review.</citation>
    <PMID>20524016</PMID>
  </reference>
  <verification_date>March 23, 2020</verification_date>
  <study_first_submitted>April 5, 2014</study_first_submitted>
  <study_first_submitted_qc>April 5, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 9, 2014</study_first_posted>
  <last_update_submitted>June 26, 2020</last_update_submitted>
  <last_update_submitted_qc>June 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 29, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Epilepsy</keyword>
  <keyword>MRI</keyword>
  <keyword>fMRI</keyword>
  <keyword>MEG</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epilepsy</mesh_term>
    <mesh_term>Epilepsies, Partial</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

